K

Kancera AB
F:3EE0

Watchlist Manager
Kancera AB
F:3EE0
Watchlist
Price: 0.0001 EUR -99.64%
Market Cap: 12.1k EUR

Relative Value

There is not enough data to reliably calculate the relative value of 3EE0.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

3EE0 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.2
Forward
0.1
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-5.1
Industry
24.2
Forward
0.1
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.5
Industry
23
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.5
Industry
25.5
vs History
96
vs Industry
38
Median 3Y
2.6
Median 5Y
3.1
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.6
Forward
-0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
0
vs Industry
Median 3Y
-2.7
Median 5Y
-3.8
Industry
6.1
Forward
-0
vs History
0
vs Industry
Median 3Y
-2.7
Median 5Y
-3.8
Industry
6.6
Forward
-0
vs History
0
vs Industry
Median 3Y
-2.7
Median 5Y
-4
Industry
8.8
vs History
0
vs Industry
Median 3Y
-2.7
Median 5Y
-4
Industry
6.8
vs History
vs Industry
30
Median 3Y
5.7
Median 5Y
7.9
Industry
5.7

Multiples Across Competitors

3EE0 Competitors Multiples
Kancera AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Kancera AB
F:3EE0
19.4m EUR 0 -0.4 0.1 0.1
IL
Can Fite Biopharma Ltd
TASE:CANF
168.5T ILS 61 044 186.9 -4 192 122 -4 113 755 -4 104 597.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
389.8B USD 6.5 166.5 16.1 22.9
US
Amgen Inc
NASDAQ:AMGN
175.3B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
153.6B USD 5.3 19 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113B USD 9.7 30.9 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.2B USD 5.5 17.2 16.3 18.4
AU
CSL Ltd
ASX:CSL
84.9B AUD 3.6 18.9 12.7 15.9
NL
argenx SE
XBRU:ARGX
42.6B EUR 13.8 32.4 55.5 57.1
P/S Multiple
Revenue Growth P/S to Growth
SE
K
Kancera AB
F:3EE0
Average P/S: 9 511 412.1
Not Available
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
61 044 186.9
140%
436 029.9
FR
Pharnext SCA
OTC:PNEXF
34 067 817
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.7
10%
1
US
E
Epizyme Inc
F:EPE
2 067.9
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
13.8
49%
0.3
P/E Multiple
Earnings Growth PEG
SE
K
Kancera AB
F:3EE0
Average P/E: 44.3
Negative Multiple: -0.4
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -4 192 122 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
166.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.9
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
10%
1.7
AU
CSL Ltd
ASX:CSL
18.9
11%
1.7
NL
argenx SE
XBRU:ARGX
32.4
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
K
Kancera AB
F:3EE0
Average EV/EBITDA: 19.3
0.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -4 113 755 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
11%
1.5
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
NL
argenx SE
XBRU:ARGX
55.5
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
K
Kancera AB
F:3EE0
Average EV/EBIT: 21.1
0.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -4 104 597.9 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
15.9
11%
1.4
NL
argenx SE
XBRU:ARGX
57.1
N/A N/A